| Literature DB >> 31495243 |
Sara M Falzarano1, Michael M Feely1.
Abstract
Entities:
Keywords: Urologic malignancy; molecular testing; prognosis; prostate cancer; renal cell carcinoma; urothelial carcinoma
Mesh:
Substances:
Year: 2019 PMID: 31495243 DOI: 10.1080/14737159.2019.1665506
Source DB: PubMed Journal: Expert Rev Mol Diagn ISSN: 1473-7159 Impact factor: 5.225